No headlines found.
Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
Business Wire (Mon, 29-Dec 4:05 PM ET)
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire (Fri, 19-Dec 4:05 PM ET)
Business Wire (Thu, 18-Dec 7:00 AM ET)
Business Wire (Tue, 9-Dec 7:00 AM ET)
Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
Business Wire (Thu, 6-Nov 4:05 PM ET)
Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
Business Wire (Wed, 5-Nov 4:05 PM ET)
Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study
Business Wire (Fri, 24-Oct 7:00 AM ET)
Business Wire (Wed, 22-Oct 4:05 PM ET)
Business Wire (Fri, 10-Oct 7:00 AM ET)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
Pulse Biosciences trades on the NASDAQ stock market under the symbol PLSE.
As of December 31, 2025, PLSE stock price climbed to $13.73 with 172,677 million shares trading.
PLSE has a beta of 0.77, meaning it tends to be less sensitive to market movements. PLSE has a correlation of 0.08 to the broad based SPY ETF.
PLSE has a market cap of $930.45 million. This is considered a Small Cap stock.
Last quarter Pulse Biosciences reported $86,000 in Revenue and -$.29 earnings per share. This fell short of revenue expectation by $-414,000 and exceeded earnings estimates by $.02.
In the last 3 years, PLSE traded as high as $25.00 and as low as $2.36.
The top ETF exchange traded funds that PLSE belongs to (by Net Assets): VTI, IWM, VXF, IWO, SCHA.
PLSE has underperformed the market in the last year with a price return of -22.3% while the SPY ETF gained +17.2%. PLSE has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -22.4% and -3.5%, respectively, while the SPY returned +2.7% and +0.7%, respectively.
PLSE support price is $13.16 and resistance is $14.24 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PLSE shares will trade within this expected range on the day.
